Revvity, Inc. (RVTY) Earnings Call Analysis
NYSE · Healthcare · Diagnostics & Research
Next earnings call: 2026-08-04
(Q2 2026)
— full calendar
Earnings Reports
-
Revity (RVTY) Q1 2026: China Divestiture Boosts Pro Forma Growth to 6%, Resets Margin Trajectory
May 05, 2026
-
Revity (RVTY) Q4 2025: $800M Buyback and 7% Diagnostics Growth Signal Strategic Flexibility
February 02, 2026
-
Revity (RVTY) Q3 2025: Software Up 20% as AI Drives Operational Leverage and Margin Resilience
October 27, 2025
-
Revity (RVTY) Q3 2025: Signals Software ARR Jumps 40%, Offsetting China Diagnostics Drag
October 27, 2025
-
Revity (RVTY) Q2 2025: China Diagnostics Down High Teens, But Software Orders Hit Record High
July 28, 2025
-
Revity (RVTY) Q1 2025: Signals Software Grows 20% as Tariff Mitigation Reshapes Margin Path
April 28, 2025
-
Revity (RVTY) Q4 2024: Software Grows 30% as Life Sciences Recovery Remains Uneven
January 31, 2025